Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals

Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals
Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Published Dec 24, 2017
73 pages — Published Dec 24, 2017
Price US$ 350.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Marketline's Sagent Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sagent Pharmaceuticals, Inc. since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Sagent Pharmaceuticals, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Sagent Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Sagent Pharmaceuticals, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Sagent Pharmaceuticals, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Sagent Pharmaceuticals, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Sagent Pharmaceuticals, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.

  
Source:
Document ID
CD767904-63C8-46E3-BBB4-5676BA6B3DF2
Industry
Ticker
US=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report" Dec 24, 2017. Alacra Store. Sep 22, 2020. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sagent-Pharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-120722>
  
APA:
MarketLine Financial Deals. (2017). Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Dec 24, 2017. New York, NY: Alacra Store. Retrieved Sep 22, 2020 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sagent-Pharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-120722>
  
US$ 350.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.